Skip to main content
GutCited
Figure 3

Description

Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.

More Figures from This Paper

Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.

Figure 2

Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.

diagram
Individual gastrointestinal symptom subscores including bloating, abdominal pain, and flatulence are presented for postbiotic and placebo groups across the study timepoints.

Figure 4

Individual gastrointestinal symptom subscores including bloating, abdominal pain, and flatulence are presented for postbiotic and placebo groups across the study timepoints.

chart

Figure 3

Chart
954 × 468px · 145.2 KB

Source Paper

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, …

Nutrients (2024)

PMID: 39599737

DOI: 10.3390/nu16223952

Cite This Figure

![Figure 3: Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.](https://pdfs.citedhealth.com/figures/39599737/180.png)

> Source: Malwina Naghibi et al. "Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Sympto." *Nutrients*, 2024. PMID: [39599737](https://pubmed.ncbi.nlm.nih.gov/39599737/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39599737/180.png" alt="Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period." />
  <figcaption>Figure 3. Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.<br>  Source: Malwina Naghibi et al. "Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Sympto." <em>Nutrients</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39599737/">39599737</a></figcaption>
</figure>

Related Evidence

B
Bifidobacterium longum for Irritable Bowel Syndrome (IBS)

Grade B · 4 studies